Tekla Capital Management LLC Regenxbio Inc. Transaction History

Tekla Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $631,253 - $991,256	-21,700 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$21.5 - $54.2 $296,700 - $747,960	-13,800 Reduced 38.87%	21,700 $703,000
Q4 2019 Feb 13, 2020	SELL	$34.54 - $44.87 $2.55 Million - $3.31 Million	-73,748 Reduced 67.51%	35,500 $1.45 Million
Q3 2019 Nov 13, 2019	BUY	$31.84 - $50.88 $3.07 Million - $4.91 Million	96,447 Added 753.43%	109,248 $3.89 Million
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $537,642 - $758,971	12,801 New	12,801 $658,000

191

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $467M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.